|
|
Antwerp BE / Schiedam NL, 2 December 2020, 7:30 CET EMBARGO
Gimv sells Itho DaalderopClimate for Life Dutch market leader in
integrated sustainable solutions for energyneutral living in the Benelux
to Parcom
Producer Itho Daalderop and service provider Klimaatgarant today announce an important step in their
development. Gimv will sell its majority... See more |
|
|
|
| |
|
| |
|
|
Antwerp BE / Medfield, MA US, 30 November 2020, 8:00 AM CET
Gimv is founding investor of Kinaset Therapeutics in a USD 40m series A
round – funds used to develop novel therapeutics for respiratory
diseases
Gimv invests in Kinaset Therapeutics alongside 5AM Ventures and Atlas Venture in a USD 40m Series A
round to support the clinical development of... See more |
|
|
|
| |
|
| |
|
|
Antwerp/Dublin, 19 November 2020, 7:30 AM CET
Gimv invests in SynOx Therapeutics which raises EUR 37 million to
develop emactuzumab for treatment of tenosynovial giant cell tumors
Gimv is investing in newly formed SynOx Therapeutics through a Series A round of EUR 37 million along
with HealthCap, Medicxi and Forbion. SynOx will continue the development of... See more |
|
|
|
| |
|
| |
|
|
Antwerp, 19 November 2020, 7:00 CET
Strong results on the back of a resilient portfolio
CEO Koen Dejonckheere:
Following the significant negative correction at the end of the previous financial year due to
the pandemic crisis, Gimv achieved a 12% return on its portfolio in the first half of the 202021
financial year. This reflects not only the... See more |
|
|
|
| |
|
| |
|
|
Antwerp BE / The Hague NL / Houten NL, 22 October 2020, 17u45 CET
Gimv and founder sell Eurocept Homecare active in ’Hospitalathome‘
services and complex wound care to Mediq
Eurocept today announces an important step in its growth. Founder Mike van Woensel and Gimv sell their
stake in Eurocept Homecare to Mediq. Mediq is part of Mediq Group, a leading... See more |
|
|
|
| |
|
| |
|
|
Search :
